Landmark brain cancer vaccine passes first phase of human trials
A new article published in the journal Nature is reporting promising results from a landmark Phase 1 human trial testing a novel vaccine designed to help a patient’s immune system better target brain tumors. The data suggests the experimental vaccine i… Continue reading Landmark brain cancer vaccine passes first phase of human trials